- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03193697
Efficacy and Safety of Cemented and Cementless Prostheses for Unstable Intertrochanteric Fractures in the Elderly
Efficacy and Safety of Cemented and Cementless Prostheses in the Repair of Unstable Intertrochanteric Fractures in the Elderly: a Prospective, Single-center, Non-randomized, Controlled, Clinical Trial With 6-month Follow-up
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background Intertrochanteric fractures are common types of hip fractures. With the growth of the global aging population, the elderly fracture patients with osteoporosis are increasing. Thus, the difficulty of treating intertrochanteric fractures increases accordingly. Unstable intertrochanteric fractures refer to the fractures from femoral neck base to lesser trochanter level. With the continuous development of China's aging trend, the number of aging population is increasing gradually; the incidence of unstable intertrochanteric fractures is increasing year by year. Clinically, more than 90% of intertrochanteric fractures occur in the elderly over 65 years of age, and the mortality rate is at a high level. Patients with unstable intertrochanteric fractures are older, and body function gradually degrades. The reduction and fixation of this disease are difficult. Therefore, early to find timely and effective treatment is of great significance to patients with unstable intertrochanteric fractures.
Clinically, internal fixation and artificial joint replacement are the primary methods of treating unstable intertrochanteric fractures. The surgical approach of internal fixation is easily affected by the bone quality of the patients. If the patient has different degrees of osteoporosis, it will lead to the failure of the first operation, affecting the prognosis of the patient. Therefore, this kind of operation method is not accepted gradually in clinical practice. The efficacy of joint replacement for treatment of intertrochanteric fracture is remarkable. It can make the patient obtain the immediate stability and reduce complications, so it is very popular with the patients and physicians in the clinic. The most commonly used artificial joint replacement materials in clinic have two types: cemented and cementless prostheses, but the difference in their efficacies and safeties remains poorly understood.
Adverse events To record adverse events, including incision pain, bone cement poisoning, pulmonary infection, mental disorders and acute cerebral infarction.
If severe adverse events occurred, investigators reported details, including the date of occurrence and measures taken to treat the adverse events, to the principle investigator and the institutional review board within 24 hours.
Data collection, management, analysis and open-access Data collection: Records of all cases reported in the trial were complete, clear and true. The case reports were consistent with the patient's original data and the declared data. The collected data were input to the computer in the record room of Harrison International Peace Hospital.
Data management: Data were processed by a special person, and aggregated once a month. During clinical trials, hospital clinic visits were conducted periodically by the clinical ombudsman to ensure that all the contents of the protocols were strictly observed. Simultaneously, raw data were checked to ensure the consistency with the case report form.
Data analysis: Statistical analysis was performed by professional statisticians. The statisticians wrote the research report and submitted it to the researcher for review.
Data open-access: Anonymized trial data will be published at www.figshare.com.
Statistical analysis Statistical analysis was performed using SPSS 19.0 software (IBM, Armonk, NY, USA) and followed the intention-to-treat principle.
Normally distributed measurement data were expressed as means ± standard deviation and minimums and maximums. Non-normally distributed measurement data were expressed as the lower quartile (q1) and median and upper quartiles (q3). Count data were expressed as the percentage. Two-sample t-test was performed for comparison of Harris hip scores, operation time, intraoperative blood loss, postoperative blood transfusion volume, ambulation time and postoperative amount of drainage in both groups. Repeated measures analysis of variance was conducted for intragroup comparison of Harris hip scores at various time points. Pearson X2 test was carried out for comparison of excellent and good rate of Harris hip scores and incidence of adverse reaction in both groups.
The significance level was α = 0.05.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Unstable intertrochanteric fractures identified by imaging and laboratory examination
- Age: Greater than 65 years old
- Irrespective of sex
- Volunteered to participate in this test, and signed informed consent
Exclusion Criteria:
- Replacement contraindications, such as acute myocardial infarction
- Obvious obstacles in language communication and communication
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: control group
Old patients with unstable intertrochanteric fractures underwent total hip arthroplasty.
Forty-four patients in the control group received a cemented SPII prosthesis (Link, Germany).
|
Old patients with unstable intertrochanteric fractures underwent total hip arthroplasty.
Forty-four patients in the control group received a cemented SPII prosthesis (Link, Germany).
Other Names:
|
EXPERIMENTAL: trial group
Old patients with unstable intertrochanteric fractures underwent total hip arthroplasty.
Forty-two patients in the trial group received cementless Wagner prosthesis (Zimmer, USA).
|
Old patients with unstable intertrochanteric fractures underwent total hip arthroplasty.
Forty-two patients in the trial group received cementless Wagner prosthesis (Zimmer, USA).
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Harris hip scores
Time Frame: at postoperative 6 months
|
To assess the recovery of hip function.The number of patients with excellent and good Harris hip scores/total number of patients × 100%.
High excellent and good rate indicates good hip function.
|
at postoperative 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
X-ray
Time Frame: Changes from preoperative 6 months to postoperative 6 months
|
To observe morphological changes in the hip.Morphology of the hip was observed in the anteroposterior and lateral images.
Heterotopic ossification was classified via the Brooker classification system.
|
Changes from preoperative 6 months to postoperative 6 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HarrisonIPH_01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intertrochanteric Fractures
-
Peking University Third HospitalBeijing Yanqing HospitalRecruitingFemoral Intertrochanteric FracturesChina
-
Peifu TangRecruitingIntertrochanteric FractureChina
-
Tel-Aviv Sourasky Medical CenterUnknownIntertrochanteric Fractures of the HipIsrael
-
Uppsala UniversityCompleted
-
Stryker Trauma GmbHGlobal Research SolutionsCompletedFemoral Neck Fractures | Intertrochanteric FractureUnited States, United Kingdom, Canada, Denmark, Germany, Australia, China, Colombia, Japan, Netherlands, Norway, South Africa
-
Stryker Trauma GmbHGlobal Research Solutions; Stryker OsteosynthesisCompletedFemoral Neck Fractures | Intertrochanteric FractureSweden, Denmark, Canada
-
King Chulalongkorn Memorial HospitalUnknownUnstable Intertrochanteric FractureThailand
-
Florida Orthopaedic InstituteUnknownHip Fracture | Intertrochanteric FractureUnited States
-
Kahramanmaras Sutcu Imam UniversityCompletedFemur Intertrochanteric FracturesTurkey
Clinical Trials on cemented SPII prosthesis
-
Sykehuset Innlandet HFRikshospitalet University Hospital; Sykehuset Buskerud HFCompleted
-
Sahlgrenska University Hospital, SwedenDePuy OrthopaedicsCompletedFemoral Neck FracturesSweden
-
NHS Greater Glasgow and ClydeZimmer Biomet; University of StrathclydeRecruitingTotal Knee Replacement | OrthopedicsUnited Kingdom
-
JointResearchUppsala University; Göteborg University; Leiden University Medical Center; OLVGEnrolling by invitation
-
Danderyd HospitalUnknownFemoral Neck FracturesSweden
-
Young Hoo KimCompleted
-
Kuopio University HospitalThe Finnish Research Foundation for Orthopaedics and TraumatologyUnknownHip Fracture | Proximal Femoral FractureFinland
-
Peking University People's HospitalFirst Affiliated Hospital of Harbin Medical University; Taoyuan General Hospital and other collaboratorsUnknown
-
Danderyd HospitalZimmer BiometActive, not recruitingHip FracturesSweden